Szerenos, N. et al. 2026. CARDIOVASCULAR BENEFITS OF GLP-1 RECEPTOR AGONISTS: EVIDENCE FROM CARDIOVASCULAR OUTCOMES TRIALS (CVOTs). International Journal of Innovative Technologies in Social Science. 1, 3(51) (Jul. 2026). DOI:https://doi.org/10.31435/ijitss.3(51).2026.6150.